πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 127 of 173

  1. US 7749720

    Methods of identifying compounds for producing insulin sensitization

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7749490

    Mutant IL-10

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7750120

    Modified vitamin K-dependent polypeptides

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7745569

    Amyloid specific binding peptides and detecting abeta peptide

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7744851

    Methods and agents for preparing 18F-radiolabeled fluorinating agents

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7745489

    Compositions and methods for inhibition of phospholipase A2 mediated inflammation

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7745468

    Compounds for treatment of cell proliferative diseases

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7745416

    Method for in vivo regulation of cardiac muscle contractility

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7745401

    Antifungal peptides and methods of use thereof

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7745407

    Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7745691

    Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7744934

    Methods for modulating eicosanoid metabolism

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7744931

    Methods for treating oral cancers with herbal compositions

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7741091

    Methods of producing hyaluronic acid and chimeric and hybrid glycosaminoglycan polymers

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7741304

    Casein kinase 2 antisense therapy

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7740867

    Method for identification of virulence determinants

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7737183

    Ξ²-amyloid and neurofibrillary tangle imaging agents

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7736646

    Methods for modulating angiogenesis with apelin compositions

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7737118

    Rotational intrathecal analgesia

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7736652

    Antibody fusion proteins: effective adjuvants of protein vaccination

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7737124

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7737174

    Indole inhibitors of MDM2 and the uses thereof

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7737266

    RNAi modulation of SCAP and therapeutics uses thereof

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7732470

    Compositions and methods for the treatment of renal and cardiovascular disease

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7732576

    Tumor suppressor designated TS10Q23.3

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7731685

    Coated medical device

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7731940

    Compositions and methods related to serotonin 5-HT1A receptors

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7732201

    Method for production of neuroblasts

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7732207

    Method for expression of small antiviral RNA molecules within a cell

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7728120

    EML4-ALK fusion gene

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7727525

    Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7727544

    Treatment of myopia

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7727554

    Sustained-release nanoparticle compositions and methods for using the same

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7727957

    Treatment and delay of outset of Parkinson's disease

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7723303

    Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7723474

    Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7723472

    Extracellular matrix binding chimeric proteins and methods of use thereof

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7723375

    Metabolites of wortmannin analogs and methods of using the same

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7723322

    Fluoride carrier for positron emission tomography

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7723104

    Cancer specific promoters

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7723071

    DNA molecules encoding opioid receptors and methods of use thereof

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7722862

    Regulatory T cells suppress autoimmunity

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7723328

    Methods of facilitating cell survival using neurotrophin mimetics

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7718618

    Human cathelicidin antimicrobial peptides

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7718684

    Methods and materials for assessing prostate cancer therapies and compounds

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7718387

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7718160

    Radiolabeled compounds and liposomes and their method of making and using same

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7718781

    Hydroxypyridonate and hydroxypyrimidinone chelating agents

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.